Boehringer Ingelheim Reveals Hidden Global Impact of Veterinary Care
Ingelheim, Germany, May 25, 2026 Boehringer Ingelheim has unveiled new findings from a large international veterinary survey revealing the...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
Ingelheim, Germany, May 25, 2026 Boehringer Ingelheim has unveiled new findings from a large international veterinary survey revealing the...
INDIANAPOLIS, INDIANA, April 27, 2026 Elanco Animal Health has received Emergency Use Authorization (EUA) from the U.S. Food and...
GREENFIELD, INDIANA, UNITED STATES — February 18, 2026 BiomEdit has initiated the pivotal field safety trial for its lead...
Libourne, France — February 9, 2026: Ceva Animal Health, the world’s fifth-largest animal health company, has announced strategic leadership...
RAHWAY, N.J. | October 23, 2025 — Merck Animal Health (MSD Animal Health outside the U.S. and Canada), a...
